Related Experiment Videos
[Cardiac resynchronization therapy in terminal heart failure: current status and prospects]
1Abteilung für Kardiologie, Zentrum für Innere Medizin, Universitätsklinikum Essen. stefan.sack@uni-essen.de
Herz
|March 22, 2001
Summary
Heart failure incidence is rising, impacting millions. AV sequential pacing improves heart function and patient outcomes, offering a new treatment avenue for heart failure.
Area of Science:
- Cardiology
- Biomedical Engineering
- Clinical Medicine
Background:
- Heart failure incidence is increasing, contrasting with declining coronary artery disease rates due to prevention efforts.
- Approximately 4-5 million new heart failure cases occur annually, with limited prognosis post-diagnosis.
- Advanced heart failure patients face a significant mortality risk, with 27% dying within 3 years.
Purpose of the Study:
- To investigate the efficacy of AV sequential pacing in improving cardiac function and clinical outcomes in heart failure patients.
- To explore the mechanisms of biventricular stimulation in resynchronizing ventricular activation and improving left ventricular function.
- To assess the potential of combining biventricular stimulation with implantable cardioverter-defibrillators for managing sudden cardiac death risk.
Main Methods:
- AV sequential pacing was introduced, involving the simultaneous activation of the right and left heart chambers.
- Biventricular stimulation was applied to patients with heart failure, severe left ventricular systolic dysfunction, and left bundle branch block.
- Ventricular resynchronization therapy was optimized by timing atrioventricular activation to reduce mitral regurgitation.
Main Results:
- AV sequential pacing improved left ventricular systolic function, ejection fraction, and NYHA classification.
- Patients experienced enhanced systolic and diastolic blood pressure, reduced resting heart rate, and improved echocardiographic parameters.
- Resynchronization of ventricles led to improved left ventricular function and diastolic relaxation, with reduced mitral regurgitation.
Conclusions:
- The prognosis of end-stage heart failure is dictated by myocardial pump failure and sudden cardiac death.
- Given the high incidence of sudden cardiac death in advanced heart failure, combining biventricular stimulation with cardioverter-defibrillator implantation is a reasonable strategy.
- This approach aims to improve overall patient survival and quality of life by addressing both pump dysfunction and arrhythmogenic risks.